Kenyatta National Hospital, Nairobi, Kenya.
Department of Epidemiology.
AIDS. 2020 Jun 1;34(7):1065-1074. doi: 10.1097/QAD.0000000000002538.
To determine clinic-level and individual-level correlates of viral suppression among HIV-positive adolescents and young adult (AYA) aged 10-24 years receiving antiretroviral treatment (ART).
Multilevel cross-sectional analysis using viral load data and facility surveys from HIV treatment programs throughout Kenya.
We abstracted medical records of AYA in HIV care, analyzed the subset on ART for more than 6 months between January 2016 and December 2017, and collected information on services at each clinic. Multilevel logistic regression models were used to determine correlates of viral suppression at most recent assessment.
In 99 HIV clinics, among 10 096 AYA on ART more than 6 months, 2683 (27%) had unsuppressed viral load at last test. Among 16% of clinics, more than 80% of AYA were virally suppressed. Clinic-level correlates of individual viral suppression included designated adolescent spaces [aOR: 1.32, 95% CI (1.07-1.63)] and faster viral load turnaround time [aOR: 1.06 (95% CI 1.03-1.09)]. Adjusting for clinic-level factors, AYA aged 10-14 and 15-19 years had lower odds of viral suppression compared with AYA aged 20-24 years [aOR: 0.61 (0.54-0.69) and 0.59 (0.52-0.67], respectively. Compared with female patients, male patients had lower odds of viral suppression [aOR: 0.69 (0.62-0.77)]. Compared with ART duration of 6-12 months, ART for 2-5, above 5-10 or more than 10 years was associated with poor viral suppression (P < 0.001).
Dedicated adolescent space, rapid viral load turnaround time, and tailored approaches for male individuals and perinatally infected AYA may improve viral suppression. Routine summarization of viral load suppression in clinics could provide benchmarking to motivate innovations in clinic-AYA and individual-AYA care strategies.
确定在接受抗逆转录病毒治疗 (ART) 的 10-24 岁艾滋病毒阳性青少年和青年 (AYA) 中,临床层面和个体层面与病毒抑制相关的因素。
利用肯尼亚各地艾滋病毒治疗项目的病毒载量数据和机构调查进行多水平横断面分析。
我们从艾滋病毒护理的 AYA 病历中提取资料,对 2016 年 1 月至 2017 年 12 月期间接受 ART 治疗超过 6 个月的 AYA 进行分析,并收集每个诊所的服务信息。采用多水平逻辑回归模型确定最近评估时病毒抑制的相关因素。
在 99 个艾滋病毒诊所中,在 10096 名接受 ART 治疗超过 6 个月的 AYA 中,有 2683 名(27%)上次检测时病毒载量未得到抑制。在 16%的诊所中,超过 80%的 AYA 病毒得到抑制。个体病毒抑制的临床层面相关因素包括指定的青少年空间[比值比 (aOR):1.32,95%置信区间 (CI):1.07-1.63]和更快的病毒载量周转时间[aOR:1.06(95%CI 1.03-1.09)]。调整诊所层面的因素后,10-14 岁和 15-19 岁的 AYA 与 20-24 岁的 AYA 相比,病毒抑制的可能性更低[aOR:0.61(0.54-0.69)和 0.59(0.52-0.67)]。与女性患者相比,男性患者病毒抑制的可能性更低[aOR:0.69(0.62-0.77)]。与 6-12 个月的 ART 相比,2-5 个月、5-10 个月或 10 个月以上的 ART 与病毒抑制不良相关(P<0.001)。
专门的青少年空间、快速的病毒载量周转时间以及针对男性个体和围生期感染 AYA 的量身定制方法,可能会提高病毒抑制率。在诊所层面定期总结病毒载量抑制情况,可以为激励诊所-AYA 和个体-AYA 护理策略方面的创新提供基准。